ArticleBMJ open2023

Cannabinol (CBN; 30 and 300 mg) effects on sleep and next-day function in insomnia disorder ('CUPID' study): protocol for a randomised, double-blind, placebo-controlled, cross-over, three-arm, proof-of-concept trial.

Isobel Lavender et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.